Advertisement

Ads Placeholder
Loading...

Abaxis, Inc.

ABAXNASDAQ
Healthcare
Medical - Equipment & Services
$83.00
$0.00(0.00%)
U.S. Market is Open • 13:10

Abaxis, Inc. Fundamental Analysis

Abaxis, Inc. (ABAX) shows weak financial fundamentals with a PE ratio of 70.66, profit margin of 11.11%, and ROE of 9.76%. The company generates N/A in annual revenue with N/A year-over-year growth of N/A.

Key Strengths

PEG Ratio0.71
Current Ratio6.02

Areas of Concern

ROE9.76%
We analyze ABAX's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of 63.1/100 based on profitability, valuation, growth, and balance sheet metrics. The C+ grade reflects average fundamentals, with notable risks in certain areas.

Fundamental Health Score

C+
63.1/100

We analyze ABAX's fundamental strength across five key dimensions:

Efficiency Score

Weak

ABAX struggles to generate sufficient returns from assets.

ROA > 10%
7.97%

Valuation Score

Moderate

ABAX shows balanced valuation metrics.

PE < 25
70.66
PEG Ratio < 2
0.71

Growth Score

Weak

ABAX faces weak or negative growth trends.

Revenue Growth > 5%
N/A
EPS Growth > 10%
N/A

Financial Health Score

Excellent

ABAX maintains a strong and stable balance sheet.

Debt/Equity < 1
0.00
Current Ratio > 1
6.02

Profitability Score

Weak

ABAX struggles to sustain strong margins.

ROE > 15%
9.76%
Net Margin ≥ 15%
11.11%
Positive Free Cash Flow
N/A

Key Financial Metrics

Is ABAX Expensive or Cheap?

P/E Ratio

ABAX trades at 70.66 times earnings. This suggests a premium valuation.

70.66

PEG Ratio

When adjusting for growth, ABAX's PEG of 0.71 indicates potential undervaluation.

0.71

Price to Book

The market values Abaxis, Inc. at 6.61 times its book value. This suggests the stock is fully valued or overvalued on an asset basis.

6.61

EV/EBITDA

Enterprise value stands at 0.92 times EBITDA. This is generally considered low.

0.92

How Well Does ABAX Make Money?

Net Profit Margin

For every $100 in sales, Abaxis, Inc. keeps $11.11 as profit after all expenses.

11.11%

Operating Margin

Core operations generate 15.80 in profit for every $100 in revenue, before interest and taxes.

15.80%

ROE

Management delivers $9.76 in profit for every $100 of shareholder equity.

9.76%

ROA

Abaxis, Inc. generates $7.97 in profit for every $100 in assets, demonstrating efficient asset deployment.

7.97%

Following the Money - Real Cash Generation

FCF Per Share

Each share generates $1.62 in free cash annually.

$1.62

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

70.66

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

0.71

vs 25 benchmark

P/B Ratio

Price to book value ratio

6.61

vs 25 benchmark

P/S Ratio

Price to sales ratio

0.00

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

0.001

vs 25 benchmark

Current Ratio

Current assets to current liabilities

6.02

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

0.10

vs 25 benchmark

ROA

Return on assets percentage

0.08

vs 25 benchmark

ROCE

Return on capital employed

0.13

vs 25 benchmark

How ABAX Stacks Against Its Sector Peers

MetricABAX ValueSector AveragePerformance
P/E Ratio70.6628.36 Worse (Expensive)
ROE9.76%751.00% Weak
Net Margin11.11%-46319.00% (disorted) Strong
Debt/Equity0.000.34 Strong (Low Leverage)
Current Ratio6.024.13 Strong Liquidity
ROA7.97%-17844.00% (disorted) Weak

ABAX outperforms its industry in 3 out of 6 key metrics, particularly excelling in Net Margin, but lagging in P/E Ratio.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Abaxis, Inc.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

N/A

Industry Style: Defensive, Growth, Innovation

EPS CAGR

N/A

Industry Style: Defensive, Growth, Innovation

FCF CAGR

N/A

Industry Style: Defensive, Growth, Innovation

Fundamental Analysis FAQ